This is the authors' abstract. We don't add key points for this paper.
As the sole nucleobase characteristic of RNA, uracil possesses a unique heterocyclic architecture that endows it with exceptional value as a privileged scaffold in medicinal chemistry. Herein, we report a versatile and efficient strategy for constructing polycyclic uracil derivatives through rare [4 + 3] cycloaddition reactions of N -aminoisoquinolinium, N -aminoquinolinium, or N -aminopyridinium salts with uracil-derived aldehydes. This protocol exhibits a broad substrate scope (36 examples), excellent functional-group tolerance, consistently high yields, and good scalability. The resulting products display diverse synthetic utility, as demonstrated by downstream derivatizations.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: